Jason D. Sadler - 01 Jul 2026 Form 3 Insider Report for Cigna Group (CI)

Reporting relationship: Title - President, Cigna Healthcare International Health / EX-24 Power of Attorney
Issuer ticker: CI
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 09 Jul 2026, 19:33:43 UTC
Prior SEC filing: 28 Feb 2023
Source filing: View source filing
Reporting owner signature: Tyler Gratton, attorney-in-fact

Key filing fact

Jason D. Sadler filed Form 3 for Cigna Group (CI) on 09 Jul 2026.

Key facts

This page summarizes Jason D. Sadler's Form 3 filing for Cigna Group (CI).
0 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 09 Jul 2026, 19:33.

Change

Previous filing in this sequence was filed on 28 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001554974 Primary reporting owner

Sadler Jason D

Relationship: Title - President, Cigna Healthcare International Health / EX-24 Power of Attorney
Address: 900 COTTAGE GROVE ROAD, BLOOMFIELD
Signature: Tyler Gratton, attorney-in-fact
Signature date: 09 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 34,705
Date: 01 Jul 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 6,257
Exercise price: $294.61
Footnotes: F1

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 5,400
Exercise price: $336.48
Footnotes: F2

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 5,791
Exercise price: $305.86
Footnotes: F3

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 3,564
Exercise price: $287.55
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This option vested in three equal annual installments beginning March 1, 2024.

Footnote F2

This option vests in three equal annual installments beginning March 1, 2025.

Footnote F3

This option vests in three equal annual installments beginning March 1, 2026.

Footnote F4

This option vests in three equal annual installments beginning March 1, 2027.

SEC remarks

Title - President, Cigna Healthcare International Health / EX-24 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .